Success of COVID-19 Vaccines Reveals Killer Flaws in Big Pharma’s Vaccine Market
“The pandemic has illustrated both political and market failures in vaccine development,” says Professor Lisa Ouellette, an intellectual property and innovation law expert at Stanford Law School. “Current COVID-19 vaccine prices are rewarding developers with only a fraction of their social value.”